CCA
NUVB icon

Castle Creek Arbitrage’s Nuvation Bio NUVB Stock Holding History

Castle Creek Arbitrage’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,228,082
Closed -$14.4M – 566
2020
Q4 		$14.4M Buy
1,228,082
+834,608
+212% +$8.68M 0.87% 22
2020
Q3 		$4.41M Buy
+393,474
New +$4.25M 0.34% 59

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Castle Creek Arbitrage's NUVB Position: Q1 2021 in Review

Castle Creek Arbitrage sold out of Nuvation Bio (NUVB) in Q1 2021, closing a stake of 1,228,082 shares — an estimated $14.4M sold.

Castle Creek Arbitrage first reported a position in NUVB in Q3 2020 and held it in 2 quarters. The position peaked at $14.4M in Q4 2020. 73 funds tracked by Wall St. Rank hold NUVB as of Q1 2021.

  • Castle Creek Arbitrage reported no remaining Nuvation Bio position as of Q1 2021 after selling out during the quarter.
  • Castle Creek Arbitrage sold 1,228,082 Nuvation Bio shares in Q1 2021, an estimated $14.4M.
  • Castle Creek Arbitrage first reported a position in Nuvation Bio in Q3 2020 and held it in 2 quarters.
  • Castle Creek Arbitrage's Nuvation Bio position peaked at $14.4M in Q4 2020.
  • 73 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2021.

Based on Castle Creek Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.